塞力医疗：持股5%以上股东上海盎泽拟减持不超2%公司股份

Core Viewpoint - The major shareholder of Saily Medical, Shanghai Angze Private Fund Management Co., Ltd., plans to reduce its stake in the company by up to 4.2028 million shares, representing no more than 2% of the total share capital, due to its own investment planning arrangements [1] Summary by Categories Shareholder Actions - The reduction of shares will occur between October 30, 2025, and January 29, 2026 [1] - The shares will be sold through centralized bidding and block trading methods, with a maximum of 2.1014 million shares to be sold via each method [1] Financial Implications - The planned reduction does not set a price range for the shares being sold [1]